ESSILOR® STELLEST® 2.0 LENSES
Made to help your child see clearly while helping manage myopia for tomorrow, the new Essilor® Stellest® 2.0 lenses are designed for children as young as 6 years old to correct myopia and help slow its progression.
The next generationof lenses.Twice the power. 1
In 2020, Essilor® unveiled the first generation of Essilor® Stellest® lenses, slowing myopia progression by 67% on average, helping millions of children worldwide.
Building on the success of the previous generation, Essilor® Stellest® 2.0 lenses provide twice the power, slowing eye growth by 1.88 times more than with the previous generation.
Benefits of Essilor Stellest 2.0 lenses
Twice the power1, higher efficiency
In the management of myopia progression (2,3)
Myopia correction
Designed to provide clear vision thanks to the clear central zone (4,5)
No compromise
Aesthetically pleasing, simple and safe (6)
Manage myopiaprogression via H.A.L.T.MAX technology (9)
Essilor® Stellest® 2.0 lenses provide twice the signal for slowing myopia progression10, delivering significantly better results11 12 vs the first generation of Essilor® Stellest® lenses. The enhanced efficacy of Essilor® Stellest® 2.0 lenses is supported by clinical trial results13.
• Correct myopia
Designed to provide sharp vision with your child’s prescription
• Myopia management
Slow myopic eye growth with H.A.L.T. MAX technology
Why choose the Essilor Stellest 2.0 lenses for your kid?
The power, higher efficacy inmanaging myopia progression.
Essilor®’s most efficacious myopiamanagement spectacle lenses.
Efficacious in myopia management forchildren as young as 6 years old (7,8).
wondering if Essilor® Stellest® 2.0 is right for your child?
Talk with an IRIS eye care professional to learn more about this innovative myopia management solution.
1.The mention "twice the power" refers to a depth of unfocused light volume (by design) twice (or more) greater than that of Essilor® Stellest® lenses,— and is not associated with a doubling of lens power, microlens power or efficiency.
2.Based on the 12-month results of a prospective, randomized, double-blind, contralateral crossover clinical trial conducted in Singapore on 50 children.
3.Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.
4.No significant difference in distance BCVA between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses when looking through the central zone of the lens (Drobe B, et al. Effect of increased power and asphericity of lenslets in myopia control spectacle lenses on short-term visual performance. Invest Ophthalmol Vis Sci. 2025;66:2144)
5.When viewed through the peripheral zone of the aspheric microlenses, no significant difference was observed between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses for high-contrast, low-contrast, and low-contrast near visual acuity (VA). (EssilorLuxottica. Internal data. 2025 Impact of increased microlens power and asphericity on the short-term visual performance of myopia control lenses.)
6.Essilor® Stellest® 2.0 lenses are made of AIRWEAR® polycarbonate which offers impact resistance and blocks 100% of UV transmission.
7.Based on the 12-month results of a prospective, randomized, double-blind, contralateral crossover clinical trial conducted in Singapore on 50 children.
8.Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.
9.HALT stands for Highly Aspherical Lenslet Target and does not mean that the progression of myopia is "stopped" or "blocked".
10.The mention "twice the power" refers to a depth of unfocused light volume (by design) twice (or more) greater than that of Essilor® Stellest® lenses, and is not associated with a doubling of lens power, microlens power or efficiency.
11.Based on the 12-month results of a prospective, randomized, double-blind, contralateral crossover clinical trial conducted in Singapore on 50 children.
12.Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.
13.Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.
*Essilor® Stellest® lenses are not currently available in all countries, including the United States, and have not been authorized by the US FDA.